Literature DB >> 7698833

Bacteremia due to Acinetobacter species other than Acinetobacter baumannii.

H Seifert1, A Strate, A Schulze, G Pulverer.   

Abstract

The objective of this study was to describe the clinical features, possible predisposing factors and treatment outcomes associated with bacteremia du to Acinetobacter species other than Acinetobacter baumannii. A review of laboratory and medical charts over a period of 18 months revealed 61 cases of bacteremia due to Acinetobacter species other than A. baumannii occurring in 59 patients. Six of these were considered not significant. Fifty cases represented catheter-related bacteremia, one case was associated with meningitis following brain surgery, and four cases could not be classified. Clinical courses wre usually benign: all but four patients were cured, but death was not related to Acinetobacter bacteremia in any case. Therapy included catheter removal alone (32.8%), appropriate antimicrobials alone (12.7%), or both (49.1%). Plasmid analysis showed distinct patterns in all strains isolated from different patients and did not reveal any epidemiological relationship among cases. Acinetobacter species other than A. baumannii are clinically significant organisms with limited pathogenic potential. They are almost exclusively involved in devise-related bacteremia. Clinical and epidemiological features of infections due to these organisms are clearly distinct from infections due to A. baumannii.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698833     DOI: 10.1007/bf01715492

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  31 in total

Review 1.  Infectious complications of indwelling vascular catheters.

Authors:  I I Raad; G P Bodey
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

2.  Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.

Authors:  T E Kiehn; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  [Epidemiology of Acinetobacter and resistance to antibiotics at hospitals. A 5-year evaluation].

Authors:  M L Joly-Guillou; E Bergogne-Berezin; J F Vieu
Journal:  Presse Med       Date:  1990-03-03       Impact factor: 1.228

4.  An outbreak of acinetobacter septicaemia in a neonatal intensive care unit.

Authors:  P C Ng; R A Herrington; C A Beane; A T Ghoneim; P R Dear
Journal:  J Hosp Infect       Date:  1989-11       Impact factor: 3.926

5.  Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus.

Authors:  E Juni
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

6.  Predominant pathogens in hospital infections.

Authors:  W R Jarvis; W J Martone
Journal:  J Antimicrob Chemother       Date:  1992-04       Impact factor: 5.790

7.  Antimicrobial susceptibility of Acinetobacter species.

Authors:  H Seifert; R Baginski; A Schulze; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.

Authors:  J Y Fagon; J Chastre; Y Domart; J L Trouillet; J Pierre; C Darne; C Gibert
Journal:  Am Rev Respir Dis       Date:  1989-04

9.  Acinetobacter peritonitis during chronic peritoneal dialysis.

Authors:  C Galvao; R Swartz; L Rocher; J Reynolds; B Starmann; D Wilson
Journal:  Am J Kidney Dis       Date:  1989-08       Impact factor: 8.860

10.  Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors:  R H Glew; R C Moellering; L J Kunz
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

View more
  11 in total

1.  Antibody response to lipopolysaccharide in patients colonized or infected with an endemic strain of Acinetobacter genomic species 13 sensu Tjernberg and Ursing.

Authors:  R Pantophlet; H Seifert; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes.

Authors:  Alexandre R Marra; Carlos Alberto P Pereira; Ana Cristina Gales; Liana C Menezes; Ruy Guilherme R Cal; José Marconi A de Souza; Michael B Edmond; Cynthia Faro; Sérgio B Wey
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species.

Authors:  Sara Martí; Jesús Rodríguez-Baño; Manuella Catel-Ferreira; Thierry Jouenne; Jordi Vila; Harald Seifert; Emmanuelle Dé
Journal:  BMC Res Notes       Date:  2011-01-11

4.  OXA-134, a naturally occurring carbapenem-hydrolyzing class D beta-lactamase from Acinetobacter lwoffii.

Authors:  Samy Figueiredo; Laurent Poirel; Harald Seifert; Pauline Mugnier; Dan Benhamou; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

5.  Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults.

Authors:  S M Poutanen; M Louie; A E Simor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

6.  Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.

Authors:  H Seifert; L Dijkshoorn; P Gerner-Smidt; N Pelzer; I Tjernberg; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Community-acquired Acinetobacter radioresistens bacteremia in an HIV-positive patient.

Authors:  P Visca; A Petrucca; P De Mori; A Festa; E Boumis; A Antinori; N Petrosillo
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

9.  Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells.

Authors:  Chul Hee Choi; Jun Sik Lee; Yoo Chul Lee; Tae In Park; Je Chul Lee
Journal:  BMC Microbiol       Date:  2008-12-10       Impact factor: 3.605

10.  Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.

Authors:  Alexandre R Marra; Sérgio B Wey; Adauto Castelo; Ana Cristina Gales; Ruy Guilherme R Cal; José R do Carmo Filho; Michael B Edmond; Carlos Alberto P Pereira
Journal:  BMC Infect Dis       Date:  2006-02-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.